🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06975358
Recruiting Not applicable

Accelerated Orthodontics With Alveolar Decortication Plus CGF Injection

NCT06975358 · tracked via the Priya Life Science Egypt tracker
Sponsor
Safa Basiouny Alawy
Phase
Not applicable
Started
2025-05-20
Last updated
2025-06-27

Condition(s) studied

Accelerate Tooth Movement

Investigational drug(s) / intervention(s)

Alveolar decortication plus CGF injectioncanine retraction without acceleration

Alveolar decortication plus CGF injection: Experimental sides will receive CGF injection (70 units) disto-buccal and disto-palatal to the maxillary canine after performing decortication. After administration of local anesthesia, two-line flap will be performed from the mesial surface of the maxillary second premolar to the distal surface of the maxillary canine Mucoperiosteal flap will be reflected in the buccal side. Two millimeters of marginal crestal bone will be held intact and using a high-speed drill and a round carbide bur (1mm diameter) under copious saline irrigation, the cortical wall will be penetrated to reach marrow spaces. Multiple perforations (10 holes for standardization) in the cortical bone will be created. The surgical site will then rinsed, and the flap will be repositioned and sutured.

canine retraction without acceleration: in the control side, the maxillary canine will be retracted without any acceleration procedure

Study summary

The aim of the present study is to evaluate alveolar bone decortication combined with CGF Injection on tooth movement acceleration

Eligibility

Sex
ALL
Min age
16 Years
Max age
22 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age of the patients ranged from 16: 22 years old. 2. Malocclusion that requires extraction of the maxillary first premolar and canine retraction (e.g. class I bimaxillary dentoalveolar protrusion and class II div 1 malocclusion). 3. Maximum anchorage needed for the maxillary arch as a part of the orthodontic treatment plan. 4. Good oral hygiene and periodontal condition. Exclusion Criteria: 1. Medically compromised patients. 2. Severe crowding in the maxillary arch. 3. Chronic intake of NSAIDs or any medication that interfere with OTM. 4. Previous orthodontic treatment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tanta University Tanta Tanta Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06975358 on ClinicalTrials.gov ↗ ← All trials in Egypt